Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. (Q51318148)

3 April 2018

title

Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. (English)

1 reference

3 April 2018

author name string

D Bobbala

1

1 reference

3 April 2018

X-L Chen

2

1 reference

3 April 2018

C Leblanc

3

1 reference

3 April 2018

M Mayhue

4

1 reference

3 April 2018

J Stankova

5

1 reference

3 April 2018

T Tanaka

6

1 reference

3 April 2018

Y-G Chen

7

1 reference

3 April 2018

S Ilangumaran

8

1 reference

3 April 2018

S Ramanathan

9

1 reference

3 April 2018

publication date

14 August 2012

1 reference

3 April 2018

published in

Diabetologia

1 reference

3 April 2018

volume

55

1 reference

3 April 2018

issue

11

1 reference

3 April 2018

page(s)

3010-3020

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-012-2675-1

exact match

0 references

cites work

Interleukin 15: biology and relevance to human disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Survival adjustment of mature dendritic cells by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

An indirect role for NK cells in a CD4(+) T-cell-dependent mouse model of type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Interleukin-2 receptor heterotrimer complex and intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

NOD x 129.H2(g7) backcross delineates 129S1/SvImJ-derived genomic regions modulating type 1 diabetes development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Antioxidant enzyme activities in IDD-prone and IDD-resistant mice: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

IL-21 signaling is critical for the development of type I diabetes in the NOD mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

New insights into the regulation of T cells by gamma(c) family cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Learning from the TGN1412 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2675-1

Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice

21 January 2018

1 reference

12 December 2020

A protocol for islet isolation from mouse pancreas

1 reference

12 December 2020

Arresting type 1 diabetes after diagnosis: GAD is not enough

1 reference

12 December 2020

Antibodies directed at mouse IL-2-R alpha and beta chains act in synergy to abolish T-cell proliferation in vitro and delayed type hypersensitivity reaction in vivo

1 reference

12 December 2020

Cellular and molecular changes accompanying the progression from insulitis to diabetes

1 reference

12 December 2020

Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex

1 reference

12 December 2020

A Subset of Interleukin-21+ Chemokine Receptor CCR9+ T Helper Cells Target Accessory Organs of the Digestive System in Autoimmunity

1 reference

12 December 2020

The role of interferon alpha in initiation of type I diabetes in the NOD mouse

1 reference

12 December 2020

Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress

1 reference

12 December 2020

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

1 reference

12 December 2020

Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response

1 reference

12 December 2020

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

12 December 2020

10.1007/S00125-012-2675-1

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

22890824

1 reference

3 April 2018